Sausage-making
2 October 2019

The $348 bln drugmaker’s low-cost deal to end a suit from two Ohio counties is a sign the painkiller-scandal litigation may cost less than expected. Financial incentives and game theory pressure hard-hit areas to come to terms quickly. Settlements may only partly cover damages.